World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular reprogramming to restore vision and fight ageing

The gene-therapy trial aims to treat glaucoma by rejuvenating cells in the optic nerve. Plus, the mystery of how things freeze and encouragement to go out into the sunlight.

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate ageing cells.